Canaccord Genuity Maintains Regeneron Pharmaceuticals (REGN) Hold Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 18, 2023, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1137410599-27899a879c9b470aba0c43f8790870ad.jpg "Deadlines for 2025 Estimated Taxes")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-981748796-dc802f776d104837b9254ea4dea29a55-3b8971ce6b104690907b3e3fd7c7c206.jpg "2025 Personal Finance Calendar")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-458984107-4b61a6c8b7614499abf70b4b3f37b200.jpg "<div>Who Are ExxonMobil's Main Competitors?</div>")